Grass pollen immunotherapy : A single year double-blind, placebo-controlled study in patients with grass pollen-induced asthma and rhinitis

Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journal

84 Scopus Citations
View graph of relations

Author(s)

  • Claudio Ortolani
  • Elide Pastorello
  • Richard B. Moss
  • Yao-Pi Hsu
  • Massimo Restuccia
  • And 5 others
  • Giovanni Joppolo
  • Antonio Miadonna
  • Umberto Cornelli
  • Georges Halpern
  • Carlo Zanussi

Detail(s)

Original languageEnglish
Pages (from-to)283-290
Journal / PublicationThe Journal of Allergy and Clinical Immunology
Volume73
Issue number2
Publication statusPublished - Feb 1984
Externally publishedYes

Abstract

Fifteen grass pollen-sensitive asthmatic patients were selected from 200 patients with grass pollenosis on the basis of positive SPTs and RASTs that were restricted to grass pollens (except Bermuda grass), no previous IT, and residence and occupation in an area monitored by serial pollen counts. They underwent a double-blind trial of specific IT with a mixture of three grass pollen-aqueous extracts (velvet, sweet vernal, and timothy) or placebo. After 10 mo, the mean maintenance dose of pollen extract (assayed by RAST inhibition) in eight actively treated patients was 6000 RAST units (range 3000 to 8000) and the mean total dose was 18,700 RAST units (range 10,200 to 30,000). Results were assessment done by the following clinical and immunological data: (1) during the pollen season, daily symptom scores; (2) PD 20% FEV1, IgE antibody to timothy by RAST in serum and in nasal secretions, serum IgG antibody to purified timothy allergen D by solid-phase radioimmunoassay, and the four IgG subclass antibodies by enzyme immunoassay were all measured before treatment and before and after the pollen season. Symptom scores of both treated patients and controls correlated with pollen counts (R=0.88, p1 or IgE antibody to timothy in serum and nasal secretions were found in the two groups before or after IT. Total IgG and all four IgG subclass antibodies to timothy antigen D increased significantly in actively treated patients (p

Citation Format(s)

Grass pollen immunotherapy : A single year double-blind, placebo-controlled study in patients with grass pollen-induced asthma and rhinitis. / Ortolani, Claudio; Pastorello, Elide; Moss, Richard B.; Hsu, Yao-Pi; Restuccia, Massimo; Joppolo, Giovanni; Miadonna, Antonio; Cornelli, Umberto; Halpern, Georges; Zanussi, Carlo.

In: The Journal of Allergy and Clinical Immunology, Vol. 73, No. 2, 02.1984, p. 283-290.

Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journal